Novel phospholipase A2 inhibitors from python serum are potent peptide antibiotics
dc.contributor.author | Samy, R. | |
dc.contributor.author | Thwin, M. | |
dc.contributor.author | Stiles, B. | |
dc.contributor.author | Satyanarayana-Jois, S. | |
dc.contributor.author | Chinnathambi, A. | |
dc.contributor.author | Zayed, M. | |
dc.contributor.author | Alharbi, S. | |
dc.contributor.author | Siveen, K. | |
dc.contributor.author | Sikka, S. | |
dc.contributor.author | Kumar, Alan Prem | |
dc.contributor.author | Sethi, G. | |
dc.contributor.author | Lim, L. | |
dc.date.accessioned | 2017-01-30T13:03:25Z | |
dc.date.available | 2017-01-30T13:03:25Z | |
dc.date.created | 2016-01-12T20:00:21Z | |
dc.date.issued | 2015 | |
dc.identifier.citation | Samy, R. and Thwin, M. and Stiles, B. and Satyanarayana-Jois, S. and Chinnathambi, A. and Zayed, M. and Alharbi, S. et al. 2015. Novel phospholipase A2 inhibitors from python serum are potent peptide antibiotics. Biochimie. 111: pp. 30-44. | |
dc.identifier.uri | http://hdl.handle.net/20.500.11937/28144 | |
dc.identifier.doi | 10.1016/j.biochi.2015.01.003 | |
dc.description.abstract |
Antimicrobial peptides (AMPs) play a vital role in defense against resistant bacteria. In this study, eight different AMPs synthesized from Python reticulatus serum protein were tested for bactericidal activity against various Gram-positive and Gram-negative bacteria (Staphylococcus aureus, Burkholderia pseudomallei (KHW and TES strains), and Proteus vulgaris) using a disc-diffusion method (20 µg/disc). Among the tested peptides, phospholipase A2 inhibitory peptide (PIP)-18[59-76], ß-Asp65-PIP[59-67], D-Ala66-PNT.II, and D60,65E-PIP[59-67] displayed the most potent bactericidal activity against all tested pathogens in a dose-dependent manner (100-6.8 µg/ml), with a remarkable activity noted against S. aureus at 6.8 µg/ml dose within 6 h of incubation. Determination of minimum inhibitory concentrations (MICs) by a micro-broth dilution method at 100-3.125 µg/ml revealed that PIP-18[59-76], ß-Asp65-PIP[59-67] and D-Ala66-PNT.II peptides exerted a potent inhibitory effect against S. aureus and B. pseudomallei (KHW) (MICs 3.125 µg/ml), while a much less inhibitory potency (MICs 12.5 µg/ml) was noted for ß-Asp65-PIP[59-67] and D-Ala66-PNT.II peptides against B. pseudomallei (TES). Higher doses of peptides had no effect on the other two strains (i.e., Klebsiella pneumoniae and Streptococcus pneumoniae).Overall, PIP-18[59-76] possessed higher antimicrobial activity than that of chloramphenicol (CHL), ceftazidime (CF) and streptomycin (ST) (30 µg/disc). When the two most active peptides, PIP-18[59-76] and ß-Asp65-PIP[59-67], were applied topically at a 150 mg/kg dose for testing wound healing activity in a mouse model of S. aureus infection, the former accelerates faster wound healing than the latter peptide at 14 days post-treatment. The western blot data suggest that the topical application of peptides (PIP-18[59-67] and ß-Asp65-PIP[59-67]) modulates NF-kB mediated wound repair in mice with relatively little haemolytic (100-1.56 µg/ml) and cytotoxic (1000-3.125 µg/ml) effects evident on human cells in vitro. | |
dc.publisher | Elsevier | |
dc.title | Novel phospholipase A2 inhibitors from python serum are potent peptide antibiotics | |
dc.type | Journal Article | |
dcterms.source.volume | 111 | |
dcterms.source.startPage | 30 | |
dcterms.source.endPage | 44 | |
dcterms.source.issn | 0300-9084 | |
dcterms.source.title | Biochimie | |
curtin.department | School of Biomedical Sciences | |
curtin.accessStatus | Fulltext not available |
Files in this item
Files | Size | Format | View |
---|---|---|---|
There are no files associated with this item. |